Event Calendar
Find out what's happening in the area of Horizon Europe, Digital Europe and Horizon 2020
Brokerage event on Horizon Europe Cluster 6 - 2023 calls
A matchmaking event on the 2023 call topics of Cluster 6 is organised by CARE4BIO project and led by NCPs. It will complement the Commission Cluster Info Days (which take place on 13 & 14 December 2022).
This virtual brokerage event will help you to build your consortium for the upcoming call topics of the Cluster 6 Work Programme. It targets a wide spectrum of stakeholders, from companies (including SMEs), universities, research organisations and other interested parties, from Europe and beyond, seeking to share new project ideas and find collaboration partners for the Horizon Europe Cluster 6 Calls 2023.
The event is free of charge, but registration is required. It is recommended to register as soon as possible. Note that only entities registered and validated by 15 December may participate in the matchmaking event. Nevertheless, the matchmaking platform will remain open until the end of January 2023.
More information and registration on the events website. Contact NCP advisor Patrick De Molder (patrick.demolder@vlaio.be) in case you have further questions or if your facing problems in this matchmaking process.
myOVERVIEW
-
sign up for personalised information
We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).
Stay informed about what matters to you.
By signing up, you can opt in for e-mail notifications and get access to
a personalised dashboard that groups all news updates and event announcements in your domain(s).
Only for stakeholders located in Flanders
Event calendar
34 upcoming events view event calendarAgro-Food, Environment Missions
Collaborative research with the global South on oceans and marine ecosytems
Testimonial
Methylomic – Hope & Improved outcomes for Crohn’s disease patients across Europe
The METHYLOMIC project, ‘targeting hope for personalised medicine in immune-mediated inflammatory diseases’ obtained funding from Horizon Europe’s Health Cluster. The project aims to personalise treatment allocation and enhance the effectiveness of medications for chronic immune-mediated diseases such as Crohn’s disease, rheumatoid arthritis, and psoriasis. BIRD, the Belgian inflammatory bowel disease research and development group, is a partner in the project and is involved in the OmiCrohn trial, a prospective randomised clinical trial for individualised therapy in Crohn’s disease patients. With BIRD’s active role in this trial, the project is set to deliver predictive, biomarker-based therapies that bring renewed hope for Crohn’s disease patients across Europe.
